학술논문
Capmatinib and Osimertinib Combination Therapy for EGFR-Mutant Lung Adenocarcinoma
Document Type
Correspondence
Source
In Journal of Thoracic Oncology January 2020 15(1):e13-e15
Subject
Language
ISSN
1556-0864